✦ LIBER ✦

Single-dose ursodeoxycholic acid therapy may be preferable in primary sclerosing cholangitis

Book ID: 120873374
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1998
Weight: 149 KB
Volume: 1157
Category: Article
ISSN: 1173-8324
DOI: 10.1007/BF03315043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose ursodeoxycholic acid (UDCA) ma

High-dose ursodeoxycholic acid (UDCA) may be beneficial in primary sclerosing cholangitis,

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

High-dose ursodeoxycholic acid as a ther

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

✍ Denise M. Harnois; Paul Angulo; Roberta A. Jorgensen; Nicholas F. LaRusso; Keith 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 270 KB

High-dose ursodeoxycholic acid as a ther

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

✍ Harnois, Denise M.; Angulo, Paul; Jorgensen, Roberta A.; Keach, Jill C.; Larusso 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 382 KB

A Preliminary Trial of High-Dose Ursodeo

A Preliminary Trial of High-Dose Ursodeoxycholic Acid in Primary Sclerosing Cholangitis

✍ Stephen A. Mitchell; Davinder S. Bansi; Nicholas Hunt; Klaus von Bergmann; Kenne 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 267 KB

High dose ursodeoxycholic acid in primar

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

✍ L. Lindström; K. M. Boberg; O. Wikman; I. Friis-Liby; R. Hultcrantz; H. Prytz; H 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Effect of high-dose ursodeoxycholic acid

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis

✍ Daniel Rost; Gerda Rudolph; Petra Kloeters-Plachky; Adolf Stiehl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

Ursodeoxycholic acid (UDCA) has beneficial effects in cholestatic liver diseases. In primary sclerosing cholangitis (PSC), there is evidence that high doses (؎20 mg/kg) of UDCA may be more effective than average doses. Biliary enrichment of UDCA at such high doses may represent the decisive factor f